Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YWHAH antisense RNA 1 (YWHAH-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 22. It is transcribed into a non-coding RNA molecule and is predicted to be located at the membrane level, but its biological function and clinical significance have not been characterized. There is no evidence that this gene encodes a functional protein or that it acts as a therapeutic target. Its association with any disease or involvement in cellular pathways remains unknown, and it is not targeted by any approved drugs or used as a biomarker in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YWHAH antisense RNA 1 (YWHAH-AS1).